Evidence map›Paper›PMID 26770579›Full record

ArticleInternational journal of clinical and experimental medicine2015

Genetic variants at 6p21, 10q23, 16q21 and 22q12 are associated with esophageal cancer risk in a Chinese Han population.

Xiaobin Jia, Peng Liu, Mingxia Zhang, Tian Feng, Hongtao Tang, Zhigang Tang, Huaqian Zhao, Tianbo Jin

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Annals of medicine · 2023
    Article
  3. Article
  4. Article
  5. BioMed research international · 2019
    Article
  6. AFrontiers in genetics · 2019
    Article
  7. Article
  8. Article
  9. Single Nucleotide Polymorphisms inFrontiers in oncology · 2018
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Xiaobin JiaThoracic Surgery, Shangluo Central Hospital Shangluo 726000, China.
Peng LiuThoracic Surgery, Yulin No. 1 Hospital Yulin 718000, China.
Mingxia ZhangSchool of Life Sciences, Northwest University Xi'an 710069, China.
Tian FengNational Engineering Research Center for Miniaturized Detection Systems Xi'an 710069, China.
Hongtao TangThoracic Surgery, Shangluo Central Hospital Shangluo 726000, China.
Zhigang TangThoracic Surgery, Shangluo Central Hospital Shangluo 726000, China.
Huaqian ZhaoThoracic Surgery, Shangluo Central Hospital Shangluo 726000, China.
Tianbo JinSchool of Life Sciences, Northwest UniversityXi'an 710069, China; National Engineering Research Center for Miniaturized Detection SystemsXi'an 710069, China.
Northwest University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveA number of recently published genome-wide association studies (GWAS) identified several genetic loci at 6p21, 10q23, 16q12 and 22q12 that were associated with digestive tract tumors, including esophageal cancer (EC). We conducted a case-control study in a Chinese Han population including 360 EC cases and 310 controls to evaluate whether these variants are related to EC susceptibility.

methodsAll these SNPs were genotyped using Sequenom Mass-ARRAY technology. For each SNP, genotypic frequencies in controls were tested for departure from Hardy-Weinberg Equilibrium (HWE) using an exact test. A P-value of 0.05 was considered the threshold for statistical significance. We compared the allele frequencies of cases and controls using the chi-squared (χ(2)) test. Associations between the gene and the risk of esophagus cancer were tested using various genetic models (co-dominant, dominant, recessive, and log-additive) and analysis by SNP stats. Odds ratios and 95% confidence intervals (CIs) were calculated by unconditional logistic regression with adjustments for age and gender.

resultsWe found significant association with risk of EC for five reported SNPs, including rs2274223 in PLCE1 at 10q23 [odds ratio (OR) = 1.390; 95% confidence interval (CI) = 1.075-1.798], rs10484761 near UNC5CL at 6p21 (OR = 1.422, 95% CI = 1.014-1.994), rs4785204 in HEATR3 at 16q12 (OR = 1.427; 95% CI = 1.116-1.824), rs4822983 in CHEK2 at 22q12 (OR = 1.361, 95% CI = 1.052-1.762), and rs738722 in CHEK2 at 22q12 (OR = 1.343, 95% CI = 1.053-1.713).

conclusionOur findings, combined with previous studies, indicated that rs10484761 at 6p21, rs2274223 at 10q23, rs4785204 at 16q12, rs4822983 and rs738722 at 22q12 may be used as genetic biomarkers for EC susceptibility in Chinese Han population.

Indexed as

Esophageal cancersingle nucleotide polymorphismsusceptibility

Identifiers

PMID26770579
PMCPMC4694479
OpenAlexW2411207856

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.